Eighteen lots of Fentanyl transdermal patches distributed in the United States have been recalled by Actavis, Inc.
The 25 mcg/hour patches may have a fold-over defect that allows active drug to be released faster than intended. In one lot of the recalled patches, one patch was found leaking gel. The remaining lots are being voluntarily recalled as a precaution.
Fentanyl is a strong opioid. The patch releases a measured amount of the drug each hour which is absorbed by skin. Damaged patches may release too much medicine, potentially causing slowed or stopped breathing that can lead to death.
Caregivers who handle damaged patches and get gel on their own skin are also at risk. Read the rest of this entry »